Estrace vs. Vivelle-Dot

See how Estrace and Vivelle-Dot compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Estrace is a daily oral tablet while Vivelle-Dot is a twice-weekly skin patch, so the main practical difference is how each one is taken.

  • Both treat menopausal hot flashes, vaginal dryness, and help prevent osteoporosis, but only Estrace is approved for palliative treatment of certain breast and prostate cancers.

  • Transdermal estrogen like Vivelle-Dot skips first-pass liver metabolism, which may carry a lower clotting risk than oral estrogen like Estrace.

Estrace vs. Vivelle-Dot Drug Summary

Estrace

Estrace is an oral estrogen (estradiol) tablet approved to treat moderate to severe hot flashes and vaginal dryness of menopause, as well as low estrogen from ovarian failure or hypogonadism. It is taken by mouth one to three times a day depending on the dose and indication, and it is also used to help prevent osteoporosis and, in some cases, to palliate certain breast and prostate cancers.

Vivelle-Dot

Vivelle-Dot is a transdermal estrogen (estradiol) patch approved to treat the same core menopausal symptoms, hot flashes and vaginal dryness, along with low estrogen from ovarian failure or hypogonadism. It is applied to the lower abdomen or buttocks and replaced twice a week, and it is also used to help prevent postmenopausal osteoporosis.

Estrace vs. Vivelle-Dot Side Effects

Estrace

Most common
Nausea (rate not quantified in label)
Breast tenderness/enlargement (rate not quantified in label)
Abdominal cramping/bloating (rate not quantified in label)
Headache (rate not quantified in label)

Vivelle-Dot

Most common
Nasopharyngitis (up to 19.6%)
Upper respiratory tract infection (up to 17%)
Sinusitis (up to 13.1%)
Sinus headache (up to 10.6%)

Estrace vs. Vivelle-Dot Dosage

Estrace

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.5 mg daily At the start
Maximum dose 10 mg three times daily If needed
Dose changes 4 increases As tolerated

Vivelle-Dot

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.025 mg/day patch At the start
Maximum dose 0.1 mg/day patch If needed
Dose changes 4 increases As tolerated

Estrace vs. Vivelle-Dot Indications

Estrace

Estrace is an oral estrogen tablet approved to treat moderate to severe hot flashes and vaginal dryness of menopause, along with low estrogen from ovarian failure or hypogonadism. It is also approved to help prevent osteoporosis and, less commonly, as palliative therapy for certain breast and prostate cancers.

  • Moderate to severe hot flashes and night sweats of menopause

  • Vaginal dryness and irritation from menopause (vulvovaginal atrophy)

  • Low estrogen from ovarian failure, hypogonadism, or ovary removal

  • Prevention of bone loss (osteoporosis) after menopause

Vivelle-Dot

Vivelle-Dot is an estradiol skin patch approved to treat the same moderate to severe hot flashes and vaginal dryness of menopause, along with low estrogen from ovarian failure or hypogonadism. It is also approved to help prevent osteoporosis after menopause, applied twice weekly to the skin.

  • Moderate to severe hot flashes and night sweats of menopause

  • Vaginal dryness and irritation from menopause (vulvovaginal atrophy)

  • Low estrogen from ovarian failure, hypogonadism, or ovary removal

  • Prevention of bone loss (osteoporosis) after menopause

Estrace vs. Vivelle-Dot Pros and Cons

Estrace

Estrace is an oral estradiol tablet with decades of clinical use since its 1975 FDA approval, and generic versions are widely available. Like all systemic estrogens, it carries boxed warnings for blood clots, stroke, and endometrial cancer risk in women with a uterus.

Pros

  • Taken by mouth, no patch site care or skin rotation needed

  • Available in multiple tablet strengths for flexible dosing

  • Decades of clinical use since its 1975 FDA approval

  • Roughly $8 to $65 per month without insurance, often generic

Cons

  • Requires daily dosing, and some regimens need multiple doses a day

  • Oral estrogen passes through the liver, a higher clotting risk than patches

  • The 2 mg tablet contains a dye that can trigger allergic reactions

Vivelle-Dot

Vivelle-Dot delivers estradiol through a twice-weekly skin patch, which some patients find more convenient than a daily pill. Like all systemic estrogens, it carries boxed warnings for blood clots, stroke, and endometrial cancer risk in women with a uterus.

Pros

  • Only applied twice a week, no daily pill to remember

  • Transdermal delivery skips the liver, a lower clotting risk than pills

  • Five patch strengths allow fine-tuned dose adjustments

  • Can shower, swim, or exercise without the patch coming off

Cons

  • Can cause skin redness or irritation at the patch site

  • Not approved for palliative treatment of breast or prostate cancer, unlike Estrace

  • Brand-name patches often cost $150 to $450 per month without insurance

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.